Tower Research Capital LLC (Trc) Genprex, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.19 - $0.37 $2,677 - $5,214	14,094 New	14,094 $3,000
Q2 2023 Aug 14, 2023	BUY	$0.74 - $1.1 $295 - $438	399 Added 4.06%	10,228 $9,000
Q1 2023 May 09, 2023	BUY	$0.76 - $1.78 $1,380 - $3,232	1,816 Added 22.66%	9,829 $9,000
Q4 2022 Feb 10, 2023	SELL	$1.0 - $58.8 $12,973 - $762,812	-12,973 Reduced 61.82%	8,013 $12,000
Q3 2022 Nov 10, 2022	BUY	$1.32 - $58.0 $25,341 - $1.11 Million	19,198 Added 1073.71%	20,986 $30,000
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.31 $8,101 - $14,619	-6,329 Reduced 77.97%	1,788 $2,000
Q1 2022 May 12, 2022	SELL	$1.82 - $3.5 $9,322 - $17,927	-5,122 Reduced 38.69%	8,117 $18,000
Q4 2021 Feb 14, 2022	BUY	$1.21 - $2.7 $5,152 - $11,496	4,258 Added 47.41%	13,239 $17,000
Q3 2021 Nov 15, 2021	BUY	$2.59 - $3.36 $23,260 - $30,176	8,981 New	8,981 $24,000
Q2 2021 Aug 16, 2021	SELL	$3.11 - $4.87 $33,062 - $51,772	-10,631 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.66 - $7.67 $16,554 - $34,691	4,523 Added 74.05%	10,631 $46,000
Q4 2020 Feb 16, 2021	SELL	$3.03 - $5.51 $64,972 - $118,150	-21,443 Reduced 77.83%	6,108 $25,000
Q3 2020 Nov 16, 2020	BUY	$2.9 - $4.29 $75,788 - $112,114	26,134 Added 1844.32%	27,551 $93,000
Q2 2020 Aug 13, 2020	BUY	$1.99 - $3.64 $2,819 - $5,157	1,417 New	1,417 $4,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $76.8M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.